GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dongkoo Bio&Pharma Co Ltd (XKRX:006620) » Definitions » Deferred Policy Acquisition Costs

Dongkoo Bio&Pharma Co (XKRX:006620) Deferred Policy Acquisition Costs


View and export this data going back to 2018. Start your Free Trial

What is Dongkoo Bio&Pharma Co Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Dongkoo Bio&Pharma Co Business Description

Traded in Other Exchanges
N/A
Address
B-14F, M State Building, 114, Beobwonro, Songpagu, Seoul, KOR, 05836
Dongkoo Bio&Pharma Co Ltd is engaged in the research, development, manufacture, and sale of pharmaceuticals products. The company provides products for digestants, other analgesics and antipyretics, nonsteroidal anti-inflammatory drugs, oral hypoglycemic agents, antiplatelet agents, antihistamines and anti-allergic, and decongestants and nasal sprays. It offers its products in multiple forms such as capsules, tablet, powder, granule, and liquid. The company exports its products to various countries including Vietnam, New Zealand, Thailand, Hong Kong and Singapore.